alexa Dairy Products as Source of Angiotensin-I-Converting Enzyme-Inhibitory (Ace-I) Peptides | Open Access Journals
ISSN: 1948-5948
Journal of Microbial & Biochemical Technology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Dairy Products as Source of Angiotensin-I-Converting Enzyme-Inhibitory (Ace-I) Peptides

Amalia Simonetti*, Annamaria Perna and Emilio Gambacorta

Department of Food and Environmental Sciences, University of Basilicata, Italy

*Corresponding Author:
Amalia S
Department of Food and Environmental Sciences
University of Basilicata, Italy
Tel: 39 0971205301
Fax: 390971205099
E-mail: [email protected]

Received date: May 15 , 2017; Accepted date: May 16, 2017; Published date: May 23, 2017

Citation: Simonetti A, Perna A, Gambacorta E (2017) Dairy Products as Source of Angiotensin-I-Converting Enzyme-Inhibitory (Ace-I) Peptides. J Microb Biochem Technol 9:e131. doi:10.4172/1948-5948.1000e131

Copyright: © 2017 Simonetti A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Microbial & Biochemical Technology

Introduction

The nutraceutical benefits derived from the protein component of dairy products on human health are now widely acknowledged. These are the result of the close association between milk protein quality and proteolytic activity of starter and non-starter bacteria, which leads to generation of secondary metabolites with healthpromoting properties. Lactic acid bacteria (LAB) such as Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus and probiotics such as Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum are commonly used as starter cultures in the dairy industry. The proteolytic activity of these LABS along with non-starter LAB, naturally present in milk, generates peptides with a wide array of biological activities, including antihypertensive, antithrombotic, opioid, immunomodulatory, antimicrobial, and antioxidant activities [1].

In recent years, the bioactive peptides with antihypertensive activity, which mainly occur through the inhibition of the angiotensin- I-converting enzyme (ACE), have gained a great deal of attention in the scientific world. ACE is a key enzyme in the regulation of blood pressure; in particular, it catalyzes the conversion of angiotensin I into angiotensin II, a potent vasoconstrictor, and inactivates bradykinin, a vasodilator [2]. Elevated ACE activity could lead to higher Angiotensin II level, giving rise to an increase in blood pressure [3]. Hypertension, closely associated to the eating habits of industrialized countries, is one of the risk factors for coronary heart disease and stroke [4].

Both casein and whey proteins, in particular α-lactalbumin and β-lactoglobulin, are a rich source of ACE-inhibitory (ACE-I) peptides [5]. These bioactive peptide sequences are usually 2-20 amino acid residues in length, encrypted and inactive within proteins but, once released, they can be absorbed through intestine to enter the blood circulation or they can produce local effect within the gastrointestinal tract [6]. They can be released in an active form by enzymes during cheesemaking, microbial fermentation and ripening and are therefore, naturally present in dairy products, whereas for the most part, they are released from milk protein sequences during gastrointestinal digestion by gastric and pancreatic enzymes [7,8].

The antihypertensive effect of fermented milk products was widely demonstrated by Sipola et al. [9] in rats and it was confirmed by Seppo et al. [10] and Jauhiainen et al. [11] in mildly hypertensive human subjects. Crippa et al. [12] showed that a daily dietary integration for 2 months with 30 g of Grana Padano cheese (typical Italian cowmilk cheese) effectively reduced blood pressure (146/91 vs. 134/83 mm Hg, before and after treatment, respectively) in hypertensive patients. Moreover, it has been demonstrated that the antihypertensive activity of protein-derived peptides is in close synergy with the milk components: Jauhiainen et al. [13] reported that fermented milk product containing ACE-I peptides, but no pure ACE-I peptides in drinking water, attenuated the development of hypertension in an animal model. It should be emphasized that bioactive peptides can also exert antihypertensive activity by interaction with opioid receptors having vasodilatatory effect and inhibiting the release of endothelin-1 (vasoconstrictor peptide) [14,15].

Taken together the results of these studies highlight that the intake of dairy products leads to an enrichment of ACE-I peptides in human body which may be useful in the non-pharmacological prevention of hypertension development.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 564
  • [From(publication date):
    June-2017 - Sep 24, 2017]
  • Breakdown by view type
  • HTML page views : 482
  • PDF downloads :82
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords